LAINGAX Trademark

Trademark Overview

On Tuesday, May 18, 2021, a trademark application was filed for LAINGAX with the United States Patent and Trademark Office. The USPTO has given the LAINGAX trademark a serial number of 90717653. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, October 31, 2024. This trademark is owned by Tanvex BioPharma, Inc.. The LAINGAX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
laingax

General Information

Serial Number90717653
Word MarkLAINGAX
Filing DateTuesday, May 18, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
Pseudo MarkLAING AX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTanvex BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-1205
KY
Party NameTanvex BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-1205
KY

Trademark Events

Event DateEvent Description
Friday, May 21, 2021NEW APPLICATION ENTERED
Monday, May 24, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, August 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 26, 2021ASSIGNED TO LIE
Monday, August 30, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, January 27, 2022ASSIGNED TO EXAMINER
Friday, January 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 1, 2022SOU EXTENSION 1 FILED
Tuesday, November 1, 2022SOU EXTENSION 1 GRANTED
Thursday, November 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 17, 2023SOU EXTENSION 2 FILED
Monday, April 17, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 2, 2023SOU EXTENSION 3 FILED
Thursday, November 2, 2023SOU EXTENSION 3 GRANTED
Saturday, November 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 26, 2024SOU EXTENSION 4 FILED
Friday, April 26, 2024SOU EXTENSION 4 GRANTED
Friday, April 26, 2024SOU TEAS EXTENSION RECEIVED
Saturday, April 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU EXTENSION 5 GRANTED
Thursday, October 31, 2024SOU EXTENSION 5 FILED

Related Keywords

laingax cancer pharmaceutical blood preparations treatments including those conditions caused treatment